An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia (Q50556086)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 31, 2010

Language	Label	Description	Also known as
English	An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia	scientific article published on October 31, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia (English)

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

0 references

author name string

Hidenobu Suzuki

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

Keishi Gen

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

Yuichi Inoue

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21047544

19 August 2024

publication date

31 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

full work available at URL

https://api.elsevier.com/content/article/PII:S0278584610004070?httpAccept=text/xml

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

https://api.elsevier.com/content/article/PII:S0278584610004070?httpAccept=text/plain

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

35

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

161-168

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

Perospirone in the treatment of schizophrenia: effect on verbal memory organization

1

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs

2

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

3

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis

4

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial

5

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Interventions for neurocognitive deficits: editor's introduction

6

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

7

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

The relationship between D 2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study

15

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

18

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

19

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

20

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

21

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

23

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

24

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Cognition, schizophrenia, and the atypical antipsychotic drugs

25

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Association of anticholinergic load with impairment of complex attention and memory in schizophrenia

26

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia

27

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

31

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia

32

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.

33

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

38

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Switching antipsychotic medications

39

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

40

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

The effects of neurocognitive remediation on executive processing in patients with schizophrenia

41

1 reference

10.1016/J.PNPBP.2010.10.021

https://api.crossref.org/works/10.1016/J.PNPBP.2010.10.021

19 August 2024

Identifiers

10.1016/J.PNPBP.2010.10.021

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21047544

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50556086&oldid=2231716113"